A Swedish register-based, long-term inception cohort study of patients with rheumatoid arthritis – results of clinical relevance

Ingiäld Hafström1, Sofia Ajeganova2,3, Maria LE Andersson4,5, Sidona-Valentina Bala6,7, Stefan Bergman5,8, Ann Bremander4,5,9, Kristina Forslind4,10, Karina Malm5,11, Björn Svensson4 1Division of Gastroenterology and Rheumatology, Department of Medicine Huddinge, Karolinsk...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Hafström I, Ajeganova S, Andersson MLE, Bala SV, Bergman S, Bremander A, Forslind K, Malm K, Svensson B
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2019
Materias:
Acceso en línea:https://doaj.org/article/8ded211658104270a511c1cb4303d61a
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:8ded211658104270a511c1cb4303d61a
record_format dspace
institution DOAJ
collection DOAJ
language EN
topic Patient reported outcomes (PRO)
disease progression
prognostic factors
lifestyle
observational study
registry
Diseases of the musculoskeletal system
RC925-935
spellingShingle Patient reported outcomes (PRO)
disease progression
prognostic factors
lifestyle
observational study
registry
Diseases of the musculoskeletal system
RC925-935
Hafström I
Ajeganova S
Andersson MLE
Bala SV
Bergman S
Bremander A
Forslind K
Malm K
Svensson B
A Swedish register-based, long-term inception cohort study of patients with rheumatoid arthritis – results of clinical relevance
description Ingiäld Hafström1, Sofia Ajeganova2,3, Maria LE Andersson4,5, Sidona-Valentina Bala6,7, Stefan Bergman5,8, Ann Bremander4,5,9, Kristina Forslind4,10, Karina Malm5,11, Björn Svensson4 1Division of Gastroenterology and Rheumatology, Department of Medicine Huddinge, Karolinska Institutet, and Rheumatology Unit, Karolinska University Hospital, Stockholm, Sweden; 2Division of Gastroenterology and Rheumatology, Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden; 3Rheumatology Division, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Brussels, Belgium; 4Faculty of Medicine, Department of Clinical Sciences, Rheumatology, Lund University, Lund, Sweden; 5Spenshult Research and Development Center, Halmstad, Sweden; 6Faculty of Medicine, Department of Health Sciences, Lund University, Lund, Sweden; 7Department of Medicine, Section of Rheumatology, Helsingborg’s Hospital, Helsingborg, Sweden; 8Primary Health Care Unit, Department of Public Health and Community Medicine, Institute of Medicine, the Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; 9Department of Regional Health Research, University of Southern Denmark, Odense, Denmark; 10Department of Research and Education, Skånevård Sund, Region Skåne, Helsingborg´s Hospital, Helsingborg, Sweden; 11Rheumatology, Capio Movement, Halmstad, SwedenCorrespondence: Ingiäld HafströmRheumatology Unit, R92, Karolinska University Hospital, 141 86 Stockholm, SwedenTel +46 73 699 6235Email ingiald.hafstrom@karolinska.sePurpose: At the end of the twentieth century, the outcome of rheumatoid arthritis (RA) was shown to be unsatisfactory and new therapeutic strategies were introduced. This initiated a register-based long-term study of early RA, the Better Anti-Rheumatic PharmacOTherapy (BARFOT) study. The aims were to evaluate the disease course and to acquire knowledge for improved care.Patients and methods: BARFOT is a multicentre observational study of patients with early RA, consecutively included 1992–2006. The patients are followed in daily practice according to a structured protocol for 15 years and data recorded in a web-based register. Also, through linkage of the BARFOT register to national registers we have acquired information on comorbidity and mortality.Results: In all, 2857 patients have been included and over 80 scientific articles have been published. Phenotypic characteristics at disease onset, i.e. gender, smoking habits and autoantibody profiles have been addressed. The disease course over 15 years was described. Early predictors for persistent disease activity, impaired function, joint damage and co-morbidities have been identified. Treatment strategies have been studied. A randomized sub-study gave strong support for the treatment of recent RA with low-dose prednisolone in combination with disease-modifying anti-rheumatic drug. Furthermore, the impact of lifestyle factors, such as smoking, alcohol consumption, body weight and physical activity has been addressed.Conclusion: A register-based study like BARFOT has provided a basis for optimal long-term management of patients with RA. In addition, the register has made it possible to perform a diversity of studies of RA addressing various issues of major relevance to the patients.Keywords: patient reported outcomes, PRO, disease progression, prognostic factors, lifestyle, observational study, registry
format article
author Hafström I
Ajeganova S
Andersson MLE
Bala SV
Bergman S
Bremander A
Forslind K
Malm K
Svensson B
author_facet Hafström I
Ajeganova S
Andersson MLE
Bala SV
Bergman S
Bremander A
Forslind K
Malm K
Svensson B
author_sort Hafström I
title A Swedish register-based, long-term inception cohort study of patients with rheumatoid arthritis – results of clinical relevance
title_short A Swedish register-based, long-term inception cohort study of patients with rheumatoid arthritis – results of clinical relevance
title_full A Swedish register-based, long-term inception cohort study of patients with rheumatoid arthritis – results of clinical relevance
title_fullStr A Swedish register-based, long-term inception cohort study of patients with rheumatoid arthritis – results of clinical relevance
title_full_unstemmed A Swedish register-based, long-term inception cohort study of patients with rheumatoid arthritis – results of clinical relevance
title_sort swedish register-based, long-term inception cohort study of patients with rheumatoid arthritis – results of clinical relevance
publisher Dove Medical Press
publishDate 2019
url https://doaj.org/article/8ded211658104270a511c1cb4303d61a
work_keys_str_mv AT hafstromi aswedishregisterbasedlongterminceptioncohortstudyofpatientswithrheumatoidarthritisndashresultsofclinicalrelevance
AT ajeganovas aswedishregisterbasedlongterminceptioncohortstudyofpatientswithrheumatoidarthritisndashresultsofclinicalrelevance
AT anderssonmle aswedishregisterbasedlongterminceptioncohortstudyofpatientswithrheumatoidarthritisndashresultsofclinicalrelevance
AT balasv aswedishregisterbasedlongterminceptioncohortstudyofpatientswithrheumatoidarthritisndashresultsofclinicalrelevance
AT bergmans aswedishregisterbasedlongterminceptioncohortstudyofpatientswithrheumatoidarthritisndashresultsofclinicalrelevance
AT bremandera aswedishregisterbasedlongterminceptioncohortstudyofpatientswithrheumatoidarthritisndashresultsofclinicalrelevance
AT forslindk aswedishregisterbasedlongterminceptioncohortstudyofpatientswithrheumatoidarthritisndashresultsofclinicalrelevance
AT malmk aswedishregisterbasedlongterminceptioncohortstudyofpatientswithrheumatoidarthritisndashresultsofclinicalrelevance
AT svenssonb aswedishregisterbasedlongterminceptioncohortstudyofpatientswithrheumatoidarthritisndashresultsofclinicalrelevance
AT hafstromi swedishregisterbasedlongterminceptioncohortstudyofpatientswithrheumatoidarthritisndashresultsofclinicalrelevance
AT ajeganovas swedishregisterbasedlongterminceptioncohortstudyofpatientswithrheumatoidarthritisndashresultsofclinicalrelevance
AT anderssonmle swedishregisterbasedlongterminceptioncohortstudyofpatientswithrheumatoidarthritisndashresultsofclinicalrelevance
AT balasv swedishregisterbasedlongterminceptioncohortstudyofpatientswithrheumatoidarthritisndashresultsofclinicalrelevance
AT bergmans swedishregisterbasedlongterminceptioncohortstudyofpatientswithrheumatoidarthritisndashresultsofclinicalrelevance
AT bremandera swedishregisterbasedlongterminceptioncohortstudyofpatientswithrheumatoidarthritisndashresultsofclinicalrelevance
AT forslindk swedishregisterbasedlongterminceptioncohortstudyofpatientswithrheumatoidarthritisndashresultsofclinicalrelevance
AT malmk swedishregisterbasedlongterminceptioncohortstudyofpatientswithrheumatoidarthritisndashresultsofclinicalrelevance
AT svenssonb swedishregisterbasedlongterminceptioncohortstudyofpatientswithrheumatoidarthritisndashresultsofclinicalrelevance
_version_ 1718398257326981120
spelling oai:doaj.org-article:8ded211658104270a511c1cb4303d61a2021-12-02T09:06:08ZA Swedish register-based, long-term inception cohort study of patients with rheumatoid arthritis – results of clinical relevance1179-156Xhttps://doaj.org/article/8ded211658104270a511c1cb4303d61a2019-09-01T00:00:00Zhttps://www.dovepress.com/a-swedish-register-based-long-term-inception-cohort-study-of-patients--peer-reviewed-article-OARRRhttps://doaj.org/toc/1179-156XIngiäld Hafström1, Sofia Ajeganova2,3, Maria LE Andersson4,5, Sidona-Valentina Bala6,7, Stefan Bergman5,8, Ann Bremander4,5,9, Kristina Forslind4,10, Karina Malm5,11, Björn Svensson4 1Division of Gastroenterology and Rheumatology, Department of Medicine Huddinge, Karolinska Institutet, and Rheumatology Unit, Karolinska University Hospital, Stockholm, Sweden; 2Division of Gastroenterology and Rheumatology, Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden; 3Rheumatology Division, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Brussels, Belgium; 4Faculty of Medicine, Department of Clinical Sciences, Rheumatology, Lund University, Lund, Sweden; 5Spenshult Research and Development Center, Halmstad, Sweden; 6Faculty of Medicine, Department of Health Sciences, Lund University, Lund, Sweden; 7Department of Medicine, Section of Rheumatology, Helsingborg’s Hospital, Helsingborg, Sweden; 8Primary Health Care Unit, Department of Public Health and Community Medicine, Institute of Medicine, the Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; 9Department of Regional Health Research, University of Southern Denmark, Odense, Denmark; 10Department of Research and Education, Skånevård Sund, Region Skåne, Helsingborg´s Hospital, Helsingborg, Sweden; 11Rheumatology, Capio Movement, Halmstad, SwedenCorrespondence: Ingiäld HafströmRheumatology Unit, R92, Karolinska University Hospital, 141 86 Stockholm, SwedenTel +46 73 699 6235Email ingiald.hafstrom@karolinska.sePurpose: At the end of the twentieth century, the outcome of rheumatoid arthritis (RA) was shown to be unsatisfactory and new therapeutic strategies were introduced. This initiated a register-based long-term study of early RA, the Better Anti-Rheumatic PharmacOTherapy (BARFOT) study. The aims were to evaluate the disease course and to acquire knowledge for improved care.Patients and methods: BARFOT is a multicentre observational study of patients with early RA, consecutively included 1992–2006. The patients are followed in daily practice according to a structured protocol for 15 years and data recorded in a web-based register. Also, through linkage of the BARFOT register to national registers we have acquired information on comorbidity and mortality.Results: In all, 2857 patients have been included and over 80 scientific articles have been published. Phenotypic characteristics at disease onset, i.e. gender, smoking habits and autoantibody profiles have been addressed. The disease course over 15 years was described. Early predictors for persistent disease activity, impaired function, joint damage and co-morbidities have been identified. Treatment strategies have been studied. A randomized sub-study gave strong support for the treatment of recent RA with low-dose prednisolone in combination with disease-modifying anti-rheumatic drug. Furthermore, the impact of lifestyle factors, such as smoking, alcohol consumption, body weight and physical activity has been addressed.Conclusion: A register-based study like BARFOT has provided a basis for optimal long-term management of patients with RA. In addition, the register has made it possible to perform a diversity of studies of RA addressing various issues of major relevance to the patients.Keywords: patient reported outcomes, PRO, disease progression, prognostic factors, lifestyle, observational study, registryHafström IAjeganova SAndersson MLEBala SVBergman SBremander AForslind KMalm KSvensson BDove Medical PressarticlePatient reported outcomes (PRO)disease progressionprognostic factorslifestyleobservational studyregistryDiseases of the musculoskeletal systemRC925-935ENOpen Access Rheumatology: Research and Reviews, Vol Volume 11, Pp 207-217 (2019)